Exagen Inc. XGN Reportable Segment — Income Tax Expense (Benefit)

Similar metrics at other companies

GBTGReportable Segment — Income Tax Expense (Benefit)

$10M-39.4%

GCMGReportable Segment — Income Tax Expense (Benefit)

$3.14M-12.7%

BKSYReportable Segment — Income Tax Expense (Benefit)

$0+100%

SNDAReportable Segment — Income Tax Expense (Benefit)

$208K+177%

GRALReportable Segment — Income Tax Expense (Benefit)

-$34.34M+14.6%

ZVRAReportable Segment — Income Tax Expense (Benefit)

-$6.91M-485%

Questions, answered.

What is Exagen Inc.'s reportable segment — income tax expense (benefit)?

Exagen Inc. (XGN) reported reportable segment — income tax expense (benefit) of $36K in Q1 2026.

What is the long-term trend for Exagen Inc.'s reportable segment — income tax expense (benefit)?

Over 2 years (2023 to 2025), Exagen Inc.'s reportable segment — income tax expense (benefit) has grown at a 24.3% compound annual growth rate (CAGR), from $33K to $51K.

What does reportable segment — income tax expense (benefit) mean?

The provision for income taxes or the benefit recognized from tax credits and deferred tax assets related to the segment's operations. This metric reflects the tax impact on the segment's financial results based on applicable tax jurisdictions. It is essential for understanding the net impact of tax policy on the segment's bottom line.